Published in J Mol Cell Cardiol on August 01, 2004
Cardiac remodeling in obesity. Physiol Rev (2008) 2.95
A murine model of isolated cardiac steatosis leads to cardiomyopathy. Hypertension (2011) 1.90
Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Fail Rev (2012) 1.61
Rodent models for metabolic syndrome research. J Biomed Biotechnol (2010) 1.53
Cardiovascular effects of leptin. Nat Rev Cardiol (2009) 1.26
Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression. Endocrinology (2009) 1.18
Role of differential signaling pathways and oxidative stress in diabetic cardiomyopathy. Curr Cardiol Rev (2010) 1.03
Diabetic cardiomyopathy: signaling defects and therapeutic approaches. Expert Rev Cardiovasc Ther (2010) 0.97
Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities. Transl Res (2014) 0.94
Metabolic dysfunction in diabetic cardiomyopathy. Heart Fail Rev (2014) 0.88
Relaxin treatment reverses insulin resistance in mice fed a high-fat diet. Diabetes (2013) 0.86
Cardiovascular changes in animal models of metabolic syndrome. J Diabetes Res (2013) 0.83
Fat utilization and arterial hypertension in overweight/obese subjects. J Transl Med (2013) 0.81
Felodipine reduces cardiac expression of IL-18 and perivascular fibrosis in fructose-fed rats. Mol Med (2008) 0.81
Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities. J Mol Cell Cardiol (2015) 0.80
Deleterious effects of lack of cardiac PAI-1 after coronary occlusion in mice and their pathophysiologic determinants. Histochem Cell Biol (2007) 0.80
Approach to assessing determinants of glucose homeostasis in the conscious mouse. Mamm Genome (2014) 0.79
Role of olmesartan in combination therapy in blood pressure control and vascular function. Vasc Health Risk Manag (2010) 0.79
Diabetic cardiomyopathy: is resistin a culprit? Cardiovasc Diagn Ther (2015) 0.77
Cardiac steatosis potentiates angiotensin II effects in the heart. Am J Physiol Heart Circ Physiol (2014) 0.77
Left ventricular systolic function deterioration during dobutamine stress echocardiography as an early manifestation of diabetic cardiomyopathy and reversal by optimized therapeutic approach. Int J Cardiovasc Imaging (2011) 0.76
Myocardial Integrated Backscatter in Obese Adolescents: Associations with Measures of Adiposity and Left Ventricular Deformation. PLoS One (2015) 0.75
Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med (2013) 24.88
A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med (2009) 12.15
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet (2007) 9.56
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet (2006) 7.01
Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res (2002) 4.92
Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet (2008) 4.17
Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J Clin Microbiol (2005) 3.82
Guidelines for diagnosis of takotsubo (ampulla) cardiomyopathy. Circ J (2007) 3.82
Genome dynamics and diversity of Shigella species, the etiologic agents of bacillary dysentery. Nucleic Acids Res (2005) 3.56
Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet (2003) 3.38
Biological features of novel avian influenza A (H7N9) virus. Nature (2013) 3.24
Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial. Stroke (2005) 2.56
Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res (2007) 2.39
Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun (2007) 2.35
Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: the Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART). J Am Coll Cardiol (2002) 2.26
Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Am J Cardiol (2006) 2.25
Virome analysis for identification of novel mammalian viruses in bat species from Chinese provinces. J Virol (2012) 2.21
Binding mode prediction and inhibitor design of anti-influenza virus diketo acids targeting metalloenzyme RNA polymerase by molecular docking. Bioinformation (2011) 2.14
Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral artery disease. Circ J (2010) 2.13
Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy. Hypertension (2004) 2.10
Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease. Circ J (2009) 2.01
Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells--implications for pregnancy-induced protection against breast cancer. Stem Cells (2008) 1.96
Indications that live poultry markets are a major source of human H5N1 influenza virus infection in China. J Virol (2011) 1.85
Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice. Arterioscler Thromb Vasc Biol (2009) 1.82
The first confirmed human case of avian influenza A (H5N1) in Mainland China. Lancet (2006) 1.79
The temporal variability of dominant frequency and complex fractionated atrial electrograms constrains the validity of sequential mapping in human atrial fibrillation. Heart Rhythm (2010) 1.74
Can exercise training with weight loss lower serum C-reactive protein levels? Arterioscler Thromb Vasc Biol (2004) 1.74
c-myc is a downstream target of the Smad pathway. J Biol Chem (2001) 1.74
Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness. J Clin Invest (2004) 1.70
Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells. Cell Motil Cytoskeleton (2004) 1.59
Two cases of systemic lupus erythematosus complicated with colonic ulcers. Intern Med (2005) 1.56
Complete genome sequence of Shigella flexneri 5b and comparison with Shigella flexneri 2a. BMC Genomics (2006) 1.54
wnt3a but not wnt11 supports self-renewal of embryonic stem cells. Biochem Biophys Res Commun (2006) 1.53
Complete genome sequence of the nitrogen-fixing and rhizosphere-associated bacterium Pseudomonas stutzeri strain DSM4166. J Bacteriol (2011) 1.46
The efficacy and tolerability of azilsartan in obese insulin-resistant mice with left ventricular pressure overload. J Cardiovasc Pharmacol (2013) 1.46
Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease a randomized, comparative, multicenter study. JACC Cardiovasc Interv (2008) 1.45
Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase. Arthritis Rheum (2008) 1.43
The impact of pharmacologic sympathetic and parasympathetic blockade on atrial electrogram characteristics in patients with atrial fibrillation. Pacing Clin Electrophysiol (2011) 1.42
Relation of severe coronary artery narrowing to insulin or thiazolidinedione use in patients with type 2 diabetes mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study). Am J Cardiol (2009) 1.42
Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study. Cancer Sci (2008) 1.42
Morphological and cytochemical determination of cell death by apoptosis. Histochem Cell Biol (2007) 1.42
Unbiased parallel detection of viral pathogens in clinical samples by use of a metagenomic approach. J Clin Microbiol (2011) 1.41
Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure. Hypertens Res (2009) 1.41
Coronary disease in type 1 diabetes: causal contiguity and clinical implications. Diabetes Care (2003) 1.38
Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis (2008) 1.37
Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer (2011) 1.37
Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Cancer Res (2003) 1.35
Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2003) 1.34
Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431. Biochem Biophys Res Commun (2008) 1.33
Inhibition of apoptosis and caspase-3 in vascular smooth muscle cells by plasminogen activator inhibitor type-1. J Cell Biochem (2004) 1.31
Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation. Circulation (2002) 1.30
Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke (2008) 1.29
Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis (2009) 1.28
Natural killer T cells accelerate atherogenesis in mice. Blood (2004) 1.28
Potential effects of nutrient profiles on nutrient intakes in the Netherlands, Greece, Spain, USA, Israel, China and South-Africa. PLoS One (2011) 1.28
Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination. Int J Cardiol (2008) 1.24
Type II NKT cells stimulate diet-induced obesity by mediating adipose tissue inflammation, steatohepatitis and insulin resistance. PLoS One (2012) 1.21
Human influenza A virus (H5N1) detection by a novel multiplex PCR typing method. J Clin Microbiol (2007) 1.19
TIMI myocardial perfusion grade and ST segment resolution: association with infarct size as assessed by single photon emission computed tomography imaging. Circulation (2002) 1.18
Long-term outcome of transoral organ-preserving pharyngeal endoscopic resection for superficial pharyngeal cancer. Gastrointest Endosc (2011) 1.18
Epigenetic regulation of ARHI in breast and ovarian cancer cells. Ann N Y Acad Sci (2003) 1.18
Sequence-dependent conformational energy of DNA derived from molecular dynamics simulations: toward understanding the indirect readout mechanism in protein-DNA recognition. J Am Chem Soc (2005) 1.18
Challenges and needs for China to eliminate rabies. Infect Dis Poverty (2013) 1.17
Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol. Thromb J (2012) 1.17
Association of TNFAIP3 interacting protein 1, TNIP1 with systemic lupus erythematosus in a Japanese population: a case-control association study. Arthritis Res Ther (2010) 1.17
Role of STAT4 polymorphisms in systemic lupus erythematosus in a Japanese population: a case-control association study of the STAT1-STAT4 region. Arthritis Res Ther (2008) 1.16
Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1. Arterioscler Thromb Vasc Biol (2006) 1.15
Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung. Cancer Sci (2009) 1.15
Lgr4 regulates mammary gland development and stem cell activity through the pluripotency transcription factor Sox2. Stem Cells (2013) 1.15
Renal function, bisphenol A, and alkylphenols: results from the National Health and Nutrition Examination Survey (NHANES 2003-2006). Environ Health Perspect (2010) 1.12
The use of global transcriptional analysis to reveal the biological and cellular events involved in distinct development phases of Trichophyton rubrum conidial germination. BMC Genomics (2007) 1.11
Relationships between plasma fatty acid composition and coronary artery disease. J Atheroscler Thromb (2010) 1.11
Reduction of coronary flow reserve in areas with and without ischemia on stress perfusion imaging in patients with coronary artery disease: a study using oxygen 15-labeled water PET. J Nucl Cardiol (2003) 1.09
Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus. Am J Cardiol (2003) 1.09
Adaptor protein Crk is required for ephrin-B1-induced membrane ruffling and focal complex assembly of human aortic endothelial cells. Mol Biol Cell (2002) 1.09
Hfq is a global regulator that controls the pathogenicity of Staphylococcus aureus. PLoS One (2010) 1.09
VCP/p97, down-regulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma. PLoS One (2012) 1.08
Impact of individual and environmental socioeconomic status on peritoneal dialysis outcomes: a retrospective multicenter cohort study. PLoS One (2012) 1.07
Replication of the association between the C8orf13-BLK region and systemic lupus erythematosus in a Japanese population. Arthritis Rheum (2009) 1.07
Crystal structure of a core domain of stomatin from Pyrococcus horikoshii Illustrates a novel trimeric and coiled-coil fold. J Mol Biol (2008) 1.07
Autophagy and cancer: dynamism of the metabolism of tumor cells and tissues. Cancer Lett (2008) 1.07
Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus. Int J Oncol (2010) 1.07
Potent inhibition of human influenza H5N1 virus by oligonucleotides derived by SELEX. Biochem Biophys Res Commun (2007) 1.07
A systematic molecular pathology study of a laboratory confirmed H5N1 human case. PLoS One (2010) 1.07
A mutant cardiac sodium channel with multiple biophysical defects associated with overlapping clinical features of Brugada syndrome and cardiac conduction disease. Cardiovasc Res (2002) 1.06
Happiness and Satisfaction with Work Commute. Soc Indic Res (2012) 1.05
Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease. Intern Med (2007) 1.05
Epiregulin as a major autocrine/paracrine factor released from ERK- and p38MAPK-activated vascular smooth muscle cells. Circulation (2003) 1.04
Therapeutic effects of antibodies to tumor necrosis factor-alpha, interleukin-6 and cytotoxic T-lymphocyte antigen 4 immunoglobulin in mice with glucose-6-phosphate isomerase induced arthritis. Arthritis Res Ther (2008) 1.04
Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication. Helicobacter (2009) 1.03
The complete sequence and analysis of the large virulence plasmid pSS of Shigella sonnei. Plasmid (2005) 1.03
Amrubicin for the treatment of neuroendocrine carcinoma of the gastrointestinal tract: a retrospective analysis of five cases. Cancer Chemother Pharmacol (2011) 1.03
[Characterization of genome of A/Guangzhou/333/99(H9N2) virus]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi (2002) 1.03
Traditional chinese medicine for senile dementia. Evid Based Complement Alternat Med (2011) 1.02
Carcinoma showing thymus-like differentiation (CASTLE) with neuroendocrine differentiation. Pathol Int (2008) 1.02